• slide
  • slide
  • slide
  • slide

Akriveia Therapeutics is discovering and developing the next generation of cancer immunotherapies. Akriveia’s new agents offer the promise of a safer and more efficacious approach to harness a patient’s own immune system to attack cancer.

About our name: “Akriveia” is a Greek word meaning “Precision” or “Accuracy” and reflects our mission to develop best-in-class immunotherapeutics through the precise targeting of our therapeutics to tumors.